Cramer’s Stop Trading: Merck CNBC Television

2.9K views - 5 months ago

Merck CEO Ken Frazier | Leadership Live with David Rubenstein David Rubenstein

15.5K views - 5 years ago

Merck to launch new clinical trial in September for five-day Covid-19 treatment CNBC Television

15K views - 5 years ago

Merck earnings beat on top and bottom lines, raises forecast CNBC Television

2.8K views - 4 years ago

Merck CEO Rob Davis on FDA approval of Keytruda injection, navigating new vaccine landscape CNBC Television

5K views - 9 months ago

Merck stock pops on earnings beat, COVID treatment sales Yahoo Finance

390 views - 4 years ago

Merck - Momma Told Me (remix) [Live Performance] Merck

23.7K views - 8 months ago

Merck Covid pill reduces death and hospitalization risk by 30%: Study CNBC Television

3.7K views - 4 years ago

(Chop It Up VOL. 2) Merck - Aint I (LIVE) FTY ENT

21.7K views - 1 year ago

Merck CEO: Antiviral pill could make Covid manageable CNBC Television

8.2K views - 4 years ago

Merck CEO Robert Davis goes one-on-one with Jim Cramer CNBC Television

12.2K views - 1 year ago

Merck, Pfizer stocks under pressure after reporting earnings Yahoo Finance

906 views - 3 years ago

What Merck's treatment means for the company, vaccine makers CNBC Television

7.9K views - 4 years ago

Merck's Keytruda gets an upgrade CNBC Television

1.3K views - 9 months ago

Chart of the Day: Merck CNBC Television

1.9K views - 1 year ago

What to know about Merck's acquisition of Acceleron Pharma CNBC Television

2.9K views - 4 years ago

Jim Cramer predicts how Merck's new Covid pill could affect market action the week of Oct. 4 CNBC Television

21.7K views - 4 years ago

Merck CEO: Pfizer and Moderna vaccines look fantastic CNBC Television

15K views - 5 years ago

Merck Ends Talks to Buy RVMD; Nvidia Invests More into CoreWeave | Stock Movers Bloomberg Podcasts

372 views - 4 months ago

Merck CEO Ken Frazier to retire at the end of June CNBC Television

2.2K views - 5 years ago